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Abstract
Background: To assess the impact of knowing central corneal thickness (CCT) on glaucoma
management in a United Kingdom district general hospital.
Methods: A masked observational non-interventional study included 304 eyes of 152 consecutive
glaucoma cases attending general clinic. CCT was measured using a hand-held pachymeter. IOP, as
measured by the Goldmann applanation tonometer (GAT), was adjusted for CCT using a
normogram. Two identical study sheets were retrospectively constructed from each subject's case
notes: one included the CCT and adjusted IOP information, the other excluded. Study sheets were
randomly presented to a single masked observer to decide glaucoma management. The difference
in management decision was noted.
Results: The mean ± standard deviation CCT was 561.5 ± 35.7 μm, 538.9 ± 41.4 μm, 538.3 ± 40.3
μm for ocular hypertension (OHT), primary open angle glaucoma (POAG) and normal pressure
glaucoma (NPG) subjects respectively. IOP adjustment was greater than ±2 mmHg in 33.9%(103/
304) of eyes. CCT and adjusted IOP information led to different treatment option in 37%(55/152).
Of the most important changes 20.4%(31/152) cases would have been commenced on additional
IOP-lowering medication, 2.0%(3/152) would have been counselled for trabeculectomy surgery and
3.3%(5/152) of the cohort would have been observed rather than treated.
Conclusion: CCT and adjusted IOP measurement can influence glaucoma management in a clinical
context. It helps attribute risk and hence aids patient management decisions.
Background
Measuring intraocular pressure (IOP) is well established,
with the Goldmann Applanantion Tonometer (GAT)
being the most widely used device. The influence of cor-
neal thickness on IOP by conventional tonometers was
acknowledged by Goldmann [1] and clarified later by
other investigators [2-6]. It has been recommended by
many that GAT readings should be complimented with
CCT measurements [2,3]. Normograms, based on varying
CCT, exist for adjusting GAT readings in normal eyes [4-
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6]. There is much controversy regarding these scales and
no single one has proven to be satisfactory as the relation-
ship between IOP and CCT is variable [3,7,8]. What is cer-
tain is CCT measurement can allow for a more accurate
estimate of the true IOP [3,5] and as IOP is the main risk
factor for the progression of glaucoma [9-11] using CCT
in routine examinations seems mandatory.
Corneal thickness can aid classification in glaucoma sus-
pects between primary open angle glaucoma (POAG),
ocular hypertension (OHT) and normal pressure glau-
coma (NPG) [12]. In addition measuring CCT was recom-
mended by the ocular hypertension studies (OHTS)
[13,14] as it is a predictive factor for the conversion of
OHT to POAG. Therefore knowledge of CCT can help to
attribute the likelihood of disease progression and assign-
ing the risk can change clinical management decisions to
reach a personalized target pressure.
We believe CCT measurement is still not a routine part of
eye examinations in some United Kingdom general clin-
ics. The aim of this experiment was to analyse any change
in management decisions based on a CCT measurement
being revealed to a masked observer. This would help
assess the influence of CCT measurements in decision
making and gauge the importance of all general ophthal-
mology clinics having access to a pachymeter.
Methods
This observational non-interventional experiment studied
304 eyes of 152 consecutive patients who attended a gen-
eral ophthalmologist's clinics with a diagnosis of glau-
coma. For the purpose of this study only cases with NPG,
POAG or OHT were included. They were classified in the
following way: POAG was defined as IOP ≥22 mmHg, in
presence of demonstrable visual field loss and/or signifi-
cant optic disc cupping. While IOP ≤ 22 mmHg with vis-
ual field loss and/or significant disc cupping cases were
defined as having NPG. OHT was defined as IOP ≥ 22
mmHg in the absence of visual field loss or significant
optic disc cupping. Exclusion criteria included any cases
below the age of 18 years, any subjects with ocular co-
morbidity such as previous corneal surgery or disease, any
subjects with a diagnosis of secondary glaucoma, or where
the diagnosis was unknown (i.e. glaucoma suspects).
Local ethics committee approval was obtained for this
study. Measurements were only taken after informed con-
sent was taken, and the tenets of the declaration of Hel-
sinki were observed. Inclusion in the study was only after
informed consent was taken. Subjects were routinely
managed in clinic as normal. They consented for their case
history to be reviewed, anonymised, summarised and that
information to be used in this study. As is normal proce-
dure in clinic IOP was measured using the GAT with top-
ical proxymetacaine 0.5% and fluorescein (Bausch &
Lomb, Rochester, New York, USA) instilled into both
eyes. The CCT measurements were recorded from a seated
patient using a hand held ultrasonic pachymeter probe
(Pachmate™ DGH 55, DGH Technology Inc, PA, USA)
gently placed in the mid-pupillary axis of the cornea in the
undilated eye. The Pachmate™ gives a mean value of CCT
taken from 25 separate measurements. All measurements
were taken by three senior ophthalmologists and both the
tonometry and pachymetry were only taken once in each
subject.
The IOP adjustment was made according to the manufac-
turer's logarithm which is based on Ehlers et al. [5], see
Table 1. All notes were retrospectively reviewed and sum-
marised by 2 investigators. Two identical study sheets
were then constructed: one included the CCT and
adjusted IOP information, the other excluding these val-
ues (Figure 1 shows an example of a study sheet). The
adjusted IOP value was made using the pachymeter man-
ufacturer's algorithm which is based on a cannulation
study done by Ehlers et al. [5].
Study sheets were shuffled and randomly presented to a
single masked observer (PH) to decide glaucoma manage-
ment. Using study sheets was an attempt to reduce any
bias from memory effects of the assessor between cases.
The investigators then recorded any differences in man-
agement decisions that had been noted by PH.
Table 1: Correction table used for adjusting IOP based on central 
corneal thickness (provided with Pachmate™ pachymeter and 
based on Ehlers et al [5]).
Central Corneal Thickness 
(Microns)
Adjustment in IOP 
(mm Hg)
445 +7
455 +6
465 +6
475 +5
485 +4
495 +4
505 +3
515 +2
525 +1
535 +1
545 0
555 -1
565 -1
575 -2
585 -3
595 -4
605 -4
615 -5
625 -6
635 -6
645 -7BMC Ophthalmology 2008, 8:1 http://www.biomedcentral.com/1471-2415/8/1
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Statistical analysis of data
Excel (Microsoft Corporation, Redmond, WA, USA) was
used to analyze and present data. The level of significance
was chosen at p < 0.05.
Results
Of 152 patients studied, 84 were male and 68 were
female. The mean age was 71.0 years (±11.5 standard
deviation years) POAG, OHT and NPG were classified in
49.3% (150/304), 34.9% (106/304) and 15.8% (48/304)
of the cohort, respectively. The mean ± standard deviation
(SD) CCT of cohort was 546.7(±40.7) μm. Mean CCT in
the POAG group was 538.3(±40.3) μm, OHT eyes it was
561.5 (±35.7) μm and in NPG eyes it was 538.3(±40.3)
μm. The difference between all three groups was statisti-
cally significant (p < 0.0001, ANOVA test).
Based on CCT readings, 33.9% (103/304) had the IOP
adjusted by greater than ±2 mmHg. 18% (54/304) of eyes
had the IOP reduced while 16.1% (49/304) had their IOP
increased. Table 2 shows details of these adjustments
made in three groups while Figure 2 shows the distribu-
tion of the adjustment to be made to IOP
Analysis of change in management decision showed that
the masked observer subsequently suggested different
treatment in 36.2% (55/152) of subjects based on CCT
being made available. These differences were divided into
2 categories: when treatment was deemed to be insuffi-
cient and upgrading of treatment was suggested (under-
treated group) and second, where it was deemed that sub-
jects were over-treated, downgrading of treatment was
suggested (over-treated group). Clinical outcomes of the
decision change are shown in Table 3.
Discussion
Clinical decision-making relies on established and quan-
tifiable parameters; these must be used rather than a reli-
ance on medical impression and intuition. The
importance of CCT is now well known and a proven
parameter [13,14]. Shih et al. [15] had a similar objective:
to ascertain whether CCT affected patient management.
Their study, although set within a specialist glaucoma
service, had similar results which showed that half their
Chart showing the frequency of each level of IOP adjustment  in the cohort, based on table 1 (correction of IOP by CCT  [5]) Figure 2
Chart showing the frequency of each level of IOP adjustment 
in the cohort, based on table 1 (correction of IOP by CCT 
[5]).
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Data collection sheet used in the study Figure 1
Data collection sheet used in the study.
Glaucoma Study Questionnaire 
         P a t i e n t   I D :  
 
         Gender:  M  /  F 
 
         D O B :  
 
 
 
 
 
1.  Best corrected visual acuities – As per optician letter 
 
Right      Left 
 
2.  Family history of glaucoma – Present/Absent 
 
3. Date  diagnosed: 
 
4.  Presenting IOP (mm Hg) 
 
Right      Left 
 
5.  Highest IOP recorded (mm Hg) 
 
Right      Left 
 
6.  Previous ocular surgery 
 
Right      Left 
 
7.  Optic Disc Cupping – CDR 
 
Right      Left 
 
8.  Visual Field Loss – 
 
Right      Left 
 
9. Other  Comments 
 
_____________________________________________________________________ 
 
10. Pachymetry (performed with DGH instrument) 
 
Right      Left 
 
11. Corrected IOP 
 
Right      Left 
Management Decision 
 
Table 2: A summary of IOP adjustment of more than 2 mm Hg 
according to the diagnosis (n = 103)
Total number IOP reduced IOP increased
POAG 50 19 31
OHT 38 29 9
NPG 15 6 9BMC Ophthalmology 2008, 8:1 http://www.biomedcentral.com/1471-2415/8/1
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study population required an adjustment of IOP ± 1.5
mmHg. What is interesting is that 8–10% of their cohort
had a change in their medication, whereas we found
nearly one third of ours would have had their treatment
changed in light of the CCT and adjusted IOP measure-
ment. This higher proportion may possibly reflect the dif-
ference in IOP correcting algorithm.
The use of normograms remains controversial. Gunvant et
al. [16] compared three formulae, including Ehler's [5],
and concluded that it and the others investigated (Ors-
sengo-Pye) may significantly over estimate the effect of
CCT on IOP measurement and lead to an overcorrection
of IOP. It is possible that if the duplicate sheets had only
contained CCT, instead of both CCT and IOP adjusted for
CCT using Ehler's algorithm, the decision made could
have been different. It would have relied on the single cli-
nician's own intuition and knowledge, and not on a
defined and quantifiable scale. Therefore we feel that
although no single algorithm for correcting factors is well
accepted; the use of such a scale was justified for this type
of experiment.
While this study only tested one senior ophthalmologist's
practice, it is clear from the results, that lack of one inves-
tigation or parameter such as CCT, can lead to a signifi-
cantly different outcome for the individual patient: a 6
month review appointment changed to counseling for
trabeculectomy surgery in 2% of the cohort. Being a theo-
retical experiment is a limitation of this study: it could be
argued that the decision maker (PH) was in an artificial
situation where patients were not actually involved, and
this could possibly change his actual decision. However
the aim of the study was to provide evidence that knowl-
edge of CCT changed management decisions and in 36%
of the cohort it did. Although only one reading of CCT
was taken in this study we are aware that it has been sug-
gested that more than one CCT measurements are
required, as there can be a significant difference between
measurements taken at different times from the same eye
[17].
Conclusion
Implementation of routine central corneal thickness
measurement could change patient management in the
general ophthalmologist's practise. We feel that a
pachymeter is an essential item of the ophthalmic equip-
ment armamentarium. The cost of such an item to a
department is small compared to being able to confi-
dently relax or step up a patient's follow-up or treatment.
CCT is one factor that is necessary to adjust IOP to achieve
a more accurate IOP and it allows monitoring for the risk
of progression to be more precise. Any decision in glau-
coma, in the absence of CCT is an uninformed one.
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